We examined levels of RTK ligands, HGF and NRG1, and found significant upregulation of these ligands in tumor tissue from erlotinib-treated mice in both A549 and HCC827 tumors (Supplementary Fig. 11A–D). Here, HGF is linked to neoplasm.